文献速递眼整形与眼眶

眼眶IgG4相关性疾病(IgG4-RD)中血清IgG2与组织IgG2浆细胞升高:在IgG4-RD评估中的潜在应用

Serum IgG2 and tissue IgG2 plasma cell elevation in orbital IgG4-related disease (IgG4-RD): Potential use in IgG4-RD assessment.
PubMed 文献 · Br J Ophthalmol · 2017-03-28

这项国际回顾性病例复习纳入69例眼眶炎性活检患者(新加坡38例、英国谢菲尔德31例,2002–2016年),分为IgG4-RD组43例、特发性眼眶炎性病变(OID)组12例和自身免疫性OID组14例。结果显示IgG4-RD、特发性和自身免疫性OID中血清IgG2和组织IgG2浆细胞均显著升高;血清IgG2截断值>5.3 g/L诊断眼眶IgG4-RD的敏感性80%、特异性91.7%、准确率0.90。作者认为IgG2可能参与IgG4-RD发病,组织IgG2与IgG4亚类报告可能提供额外信息。

要点

  • 双免疫组化显示IgG2浆细胞与IgG4浆细胞为不同细胞群。
  • IgG4-RD、特发性和自身免疫性OID中血清IgG2均显著(两倍)升高。
  • 血清IgG2>5.3 g/L诊断眼眶IgG4-RD敏感性80%、特异性91.7%、准确率0.90。

核心结论

  • 眼眶IgG4-RD中血清IgG2与组织IgG2浆细胞较非IgG4眼眶炎症(特发性和自身免疫性OID)显著升高,提示IgG2可能参与IgG4-RD的发病。

研究设计与样本

  • 国际(英国谢菲尔德与新加坡)协作的回顾性病例复习,纳入2002至2016年间69例眼眶炎性活检患者,其中新加坡国家眼科中心38例、谢菲尔德皇家哈勒姆郡医院31例。
  • 病例分为三组:第1组IgG4-RD眼眶炎症43例,第2组特发性OID 12例,第3组自身免疫性OID 14例;复习临床信息与组织学,并在可得时收集血清IgG1、IgG2、IgG3、IgG4水平,对组织IgG2浆细胞行免疫组化(IHC)。

主要发现

  • 双免疫组化显示IgG2浆细胞是与IgG4浆细胞不同的一群细胞。
  • IgG4-RD(第1组)、特发性OID(第2组)和自身免疫性OID(第3组)中均观察到血清IgG2显著(两倍)升高。
  • IgG4-RD(第1组)、特发性OID与自身免疫性OID(第2、3组)中同样观察到组织IgG2浆细胞显著升高。

关键数值与推荐

  • 血清IgG2截断值>5.3 g/L诊断眼眶IgG4-RD的敏感性为80%、特异性为91.7%,准确率为0.90。

临床怎么用

  • 作者认为组织IgG2与IgG4亚类报告可能提供关于「IgG4-RD」发病机制的额外信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To determine the role of serum and tissue IgG2 in orbital biopsies with the histological features of IgG4-related disease (IgG4-RD) in comparison with non-IgG4-related orbital inflammatory disorders (OID), including autoimmune disorders. METHODS: This is an international (Sheffield, UK, and Singapore) collaborative, retrospective case review of 69 patients (38 from Singapore National Eye Centre and 31 from Royal Hallamshire Hospital, Sheffield) with orbital inflammatory biopsies between 2002 and 2016. Clinical information and histology were reviewed and cases were classified into three groups: Group 1: IgG4-RD orbital inflammation (n=43); Group 2: idiopathic OID (n=12) and Group 3: autoimmune OID (n=14). Serum IgG1, IgG2, IgG3 and IgG4 levels were collated where available and immunohistochemistry (IHC) for tissue IgG2 plasma cells was performed. RESULTS: Dual IHC showed IgG2 plasma cells as a distinct population from IgG4 plasma cells. Significant (twofold) serum IgG2 elevation was noted among IgG4-RD (group 1), idiopathic (group 2) and autoimmune OID (group 3). Similarly, significant elevation of tissue IgG2 plasma cells was also seen among IgG4-RD (group 1), idiopathic and autoimmune OID (groups 2 and 3). CONCLUSIONS: Significant elevations of serum IgG2 and tissue IgG2 plasma cells are present in orbital IgG4-RD in comparison with non-IgG4 orbital inflammation (idiopathic and autoimmune OID), suggesting that IgG2 may play a role in IgG4-RD. A serum IgG2 cut-off >5.3 g/L was found to be 80% sensitive and 91.7% specific for orbital IgG4-RD, with an accuracy of 0.90. Tissue IgG2 and IgG4 subclass reporting may provide additional insight regarding the 'IgG4-RD' pathogenesis.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Chan ASY, Mudhar H, Shen SY, et al. Serum IgG2 and tissue IgG2 plasma cell elevation in orbital IgG4-related disease (IgG4-RD): Potential use in IgG4-RD assessment. Br J Ophthalmol. 2017. PMID: 28351925. doi:10.1136/bjophthalmol-2017-310148

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。